Iverhart Max Lot Recalled On Efficacy Concern



Published:

Virbac is recalling one lot of its canine heartworm preventative Iverhart Max Chewable Tablets.

Virbac Animal Health voluntarily recalled one lot of its canine heartworm and internal parasite preventive Iverhart Max Chewable Tablets (ivermectin, pyrantel pamoate, praziquantel) because the ivermectin failed to meet the company’s stability specifications.

Some dogs dosed with tablets from the affected lot (#110482 for large dogs, 50.1 to 100 lbs.) may not be protected against heartworm disease, the company said.

The lot number is stamped on the side lid or flap of the product’s box in a white text field and on the blister foil of the individual doses.

Virbac, of Fort Worth, Texas, sent letters to veterinary distributors instructing them to cease distribution of the affected lot and to advise veterinary clinics in receipt of the recalled product to cease dispensing it.

The other active ingredients in Iverhart were not affected, the company said, meaning the tablets should provide protection against other internal parasites. Virbac tested other lots of Iverhart and confirmed only one lot was affected.

No heartworm-related adverse events or illnesses had been reported to Virbac as of late March. If veterinarians see a potentially affected dog, they should contact Virbac Technical Services at 1-800-338-3659 x3052) to discuss testing procedures. If a dog taking the product is infected with heartworms, its treatment will be covered under the Iverhart product satisfaction guarantee, the company said.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Study May Lead to Early Diagnosis of Feline Kidney Disease

The biomarker SDMA identified the onset of kidney disease an average of 17 months earlier in cats and in one case four years earlier.

Merck Launches Overseas Veterinarian Exchange

The Nobivac Global Vet Exchange Program allows practitioners to observe how veterinary medicine is performed in other countries.

Petco Buying Drs. Foster and Smith

Co-founders Race Foster and Marty Smith will stay with Drs. Foster and Smith when Petco takes ownership and branches into drug sales in early 2015.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module